Allianz’s Genenta Science GNTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$431K Hold
234,050
﹤0.01% 350
2026
Q1
$157K Hold
234,050
﹤0.01% 394
2025
Q4
$349K Hold
234,050
﹤0.01% 313
2025
Q3
$744K Hold
234,050
0.02% 245
2025
Q2
$713K Buy
234,050
+500
+0.2% +$1.95K 0.02% 231
2025
Q1
$927K Buy
233,550
+130,300
+126% +$524K 0.02% 237
2024
Q4
$444K Hold
103,250
0.01% 271
2024
Q3
$441K Buy
103,250
+10,050
+11% +$40.3K 0.01% 255
2024
Q2
$289K Hold
93,200
0.01% 304
2024
Q1
$326K Buy
+93,200
New +$382K 0.01% 290

Other funds holding GNTA

Allianz's GNTA Position: Q2 2026 in Review

Allianz held its Genenta Science (GNTA) position steady in Q2 2026 at 234,050 shares worth $431K. The position accounts for ﹤0.01% of the portfolio, ranked #350.

Allianz first reported a position in GNTA in Q1 2024 and has held it in 10 quarters since. The position peaked at $927K in Q1 2025. 9 funds tracked by Wall St. Rank hold GNTA as of Q2 2026.

  • Allianz held 234,050 shares of Genenta Science worth $431K as of Q2 2026.
  • Allianz left its Genenta Science share count unchanged in Q2 2026.
  • Genenta Science made up ﹤0.01% of Allianz's portfolio in Q2 2026, its #350 holding.
  • Allianz first reported a position in Genenta Science in Q1 2024 and has held it in 10 quarters since.
  • Allianz's Genenta Science position peaked at $927K in Q1 2025.
  • 9 funds tracked by Wall St. Rank held Genenta Science as of Q2 2026.

Based on Allianz's 13F filing for Q2 2026, filed 10 Aug 2026.